ShiraTronics

[Image courtesy of ShiraTronics]ShiraTronics announced that it completed enrollment in a pilot study of its minimally invasive implantable migraine therapy.

Minneapolis-based ShiraTronics designed its neuromodulation system to address the debilitating symptoms of migraines. The company says it offers the first-ever fully implantable system for head location utilizing a minimally invasive approach.

The fully implantable, programmable device delivers precise electrical pulses tailored to disrupt migraine pain signals. ShiraTronics designed it to offer a new and potentially more effective treatment option. The device won FDA breakthrough device designation in 2021. The company completed the first six implants of the device in this RELIEV-CM pilot study in December 2023. It takes place in Australia in collaboration with leading neurology and pain management researchers.

ShiraTronics said that, in the pilot’s initial stages, data unveiled promising results…

[Image courtesy of ShiraTronics]ShiraTronics announced the successful implantation of its Chronic Migraine System in the world’s first six patients.

Minneapolis-based ShiraTronics designed the neuromodulation system to address the debilitating symptoms of migraines. The company says it offers the first-ever fully implantable system for head location utilizing a minimally invasive approach.

The fully implantable, programmable device delivers electrical pulses tailored to disrupt migraine pain signals. ShiraTronics designed it to offer a new and potentially more effective treatment option. The device won FDA breakthrough device designation in 2021.

“It is gratifying and humbling to witness the evolution of this innovative approach to treating chronic migraine. Originating as a visionary concept by a creative group of physicians, it has now materialized into a tangible reality that has the potential to restore quality of life to many enduring this …